MICHAEL E RYTTING to Clinical Trials, Phase I as Topic
This is a "connection" page, showing publications MICHAEL E RYTTING has written about Clinical Trials, Phase I as Topic.
Connection Strength
0.012
-
Population pharmacokinetics of clofarabine, a second-generation nucleoside analog, in pediatric patients with acute leukemia. J Clin Pharmacol. 2004 Nov; 44(11):1309-22.
Score: 0.012